Therapeutic Area | MeSH |
---|---|
eye diseases | D005128 |
immune system diseases | D007154 |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
CHILDREN'S ALAWAY | Bausch Health Companies | N-021996 OTC | 2015-02-11 | 1 products, RLD |
ALAWAY | Bausch Health Companies | N-021996 OTC | 2006-12-01 | 1 products, RLD, RS |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
allergic conjunctivitis | EFO_0007141 | D003233 | H10.44 |
Expiration | Code | ||
---|---|---|---|
KETOTIFEN FUMARATE, ACUVUE THERAVISION WITH KETOTIFEN, JOHNSON JOHNSON VISN | |||
2025-02-25 | NP |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Allergic conjunctivitis | D003233 | EFO_0007141 | H10.44 | 1 | 2 | 11 | 1 | 1 | 16 |
Asthma | D001249 | EFO_0000270 | J45 | — | — | — | 1 | — | 1 |
Pleural effusion | D010996 | HP_0002202 | J90 | — | — | — | 1 | — | 1 |
Dengue | D003715 | — | A90 | — | — | — | 1 | — | 1 |
St elevation myocardial infarction | D000072657 | — | — | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Allergic rhinitis perennial | D012221 | EFO_1001417 | J30.89 | — | — | 2 | — | — | 2 |
Lens subluxation | D007906 | HP_0001132 | H27.1 | — | — | 1 | — | — | 1 |
Chronic pain | D059350 | HP_0012532 | — | — | — | 1 | — | — | 1 |
Atopic dermatitis | D003876 | EFO_0000274 | L20 | — | — | 1 | — | — | 1 |
Dermatitis | D003872 | HP_0011123 | L30.9 | — | — | 1 | — | — | 1 |
Fibromyalgia | D005356 | EFO_0005687 | M79.1 | — | — | 1 | — | — | 1 |
Respiratory tract infections | D012141 | — | J06.9 | — | — | 1 | — | — | 1 |
Peripheral nervous system diseases | D010523 | HP_0009830 | G64 | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Visual acuity | D014792 | — | — | — | 1 | — | — | — | 1 |
Peanut hypersensitivity | D021183 | EFO_0007425 | — | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Pruritus | D011537 | HP_0000989 | L29 | — | — | — | — | 1 | 1 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | — | — | — | — | 1 | 1 |
Pathologic dilatation | D004108 | — | — | — | — | — | — | 1 | 1 |
Keratoconus | D007640 | EFO_0004223 | H18.6 | — | — | — | — | 1 | 1 |
Fuchs' endothelial dystrophy | D005642 | EFO_0003946 | H18.51 | — | — | — | — | 1 | 1 |
Drug common name | Ketotifen |
INN | ketotifen |
Description | Ketotifen is an organic heterotricyclic compound that is 4,9-dihydro-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one which is substituted at position 4 by a 1-methylpiperidin-4-ylidene group. A blocker of histamine H1 receptors with a stabilising action on mast cells, it is used (usually as its hydrogen fumarate salt) for the treatment of asthma, where it may take several weeks to exert its full effect. It has a role as a H1-receptor antagonist and an anti-asthmatic drug. It is an organosulfur heterocyclic compound, an organic heterotricyclic compound, a cyclic ketone, a member of piperidines, an olefinic compound and a tertiary amino compound. It is a conjugate base of a ketotifen(1+). |
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | CN1CCC(=C2c3ccccc3CC(=O)c3sccc32)CC1 |
PDB | — |
CAS-ID | 34580-13-7 |
RxCUI | — |
ChEMBL ID | CHEMBL534 |
ChEBI ID | — |
PubChem CID | 3827 |
DrugBank | DB00920 |
UNII ID | X49220T18G (ChemIDplus, GSRS) |